serw-MX  [xml]  
 


    
 DeCS Categories

C10 Nervous System Diseases .
C10.668 Neuromuscular Diseases .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.663 Peripheral Nervous System Agents .
D27.505.696.663.700 Neuromuscular Agents .
E03 Anesthesia and Analgesia .
E03.706 Neuromuscular Blockade .
E05 Investigative Techniques .
E05.635 Neuromuscular Blockade .
G07 Physiological Phenomena .
G07.265 Electrophysiological Phenomena .
G07.265.753 Neural Conduction .
G07.265.753.770 Refractory Period, Electrophysiological .
G07.265.760 Refractory Period, Electrophysiological .
G11 Musculoskeletal and Neural Physiological Phenomena .
G11.561 Nervous System Physiological Phenomena .
G11.561.601 Neural Conduction .
G11.561.601.770 Refractory Period, Electrophysiological .
G11.561.785 Refractory Period, Electrophysiological .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Refractory Period, Electrophysiological .
Inhibition, Vvedenskii .
Inhibition, Wedensky .
Neurologic Refractory Period .
Neurologic Refractory Periods .
Neuromuscular Fade .
Neuromuscular Transmission Fade .
Refractory Period, Neurological .
Refractory Periods, Neurologic .
Electrophysiological Refractory Period .
Electrophysiological Refractory Periods .
Fade, Neuromuscular .
Fade, Neuromuscular Transmission .
Fade, Tetanic .
Neurological Refractory Period .
Neurological Refractory Periods .
Refractory Periods, Electrophysiological .
Refractory Periods, Neurological .
Transmission Fade, Neuromuscular .
Period, Neurologic Refractory .
Periods, Neurologic Refractory .
Refractory Period, Neurologic .
Tetanic Fade .
Vvedenskii Inhibition .
Wedensky Inhibition .
The period of time following the triggering of an ACTION POTENTIAL when the CELL MEMBRANE has changed to an unexcitable state and is gradually restored to the resting (excitable) state. During the absolute refractory period no other stimulus can trigger a response. This is followed by the relative refractory period during which the cell gradually becomes more excitable and the stronger impulse that is required to illicit a response gradually lessens to that required during the resting state. .
1.00
52596
 
Neuromuscular Agents .
Neuromuscular Effect .
Neuromuscular Effects .
Agents, Neuromuscular .
Effect, Neuromuscular .
Effects, Neuromuscular .
Muscle Relaxants, Skeletal .
Relaxants, Skeletal Muscle .
Skeletal Muscle Relaxants .
Drugs used for their actions on skeletal muscle. Included are agents that act directly on skeletal muscle, those that alter neuromuscular transmission (NEUROMUSCULAR BLOCKING AGENTS), and drugs that act centrally as skeletal muscle relaxants (MUSCLE RELAXANTS, CENTRAL). Drugs used in the treatment of movement disorders are ANTI-DYSKINESIA AGENTS. .
0.62
1134939
 
Neuromuscular Diseases .
Cramp-Fasciculation Syndrome .
Fasciculation-Cramp Syndrome, Benign .
Foley-Denny-Brown Syndrome .
Oppenheim's Disease .
Benign Fasciculation-Cramp Syndrome .
Benign Fasciculation-Cramp Syndromes .
Cramp Fasciculation Syndrome .
Cramp-Fasciculation Syndromes .
Fasciculation Cramp Syndrome, Benign .
Fasciculation-Cramp Syndromes, Benign .
Foley Denny Brown Syndrome .
Neuromuscular Disease .
Oppenheims Disease .
Syndrome, Cramp-Fasciculation .
Syndrome, Foley-Denny-Brown .
Syndromes, Cramp-Fasciculation .
Amyotonia Congenita .
Oppenheim Disease .
MYATONIA CONGENITA .
OPPENHEIM'S DISEASE .
A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA. .
0.62
2339320
 
Neuromuscular Blockade .
Neuromuscular Block .
Block, Neuromuscular .
Blockade, Neuromuscular .
The intentional interruption of transmission at the NEUROMUSCULAR JUNCTION by external agents, usually neuromuscular blocking agents. It is distinguished from NERVE BLOCK in which nerve conduction (NEURAL CONDUCTION) is interrupted rather than neuromuscular transmission. Neuromuscular blockade is commonly used to produce MUSCLE RELAXATION as an adjunct to anesthesia during surgery and other medical procedures. It is also often used as an experimental manipulation in basic research. It is not strictly speaking anesthesia but is grouped here with anesthetic techniques. The failure of neuromuscular transmission as a result of pathological processes is not included here. .
0.61
1061845